These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29241924)

  • 1. Effects of growth hormone plus gonadotropins on controlled ovarian stimulation in infertile women of advanced age, poor responders, and previous in vitro fertilization failure patients.
    Ho YK; Lee TH; Lee CI; Cheng EH; Huang CC; Huang LS; Lee MS
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):806-810. PubMed ID: 29241924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study.
    Choe SA; Kim MJ; Lee HJ; Kim J; Chang EM; Kim JW; Park HM; Lyu SW; Lee WS; Yoon TK; Kim YS
    Arch Gynecol Obstet; 2018 Mar; 297(3):791-796. PubMed ID: 29264647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis.
    Cozzolino M; Cecchino GN; Troiano G; Romanelli C
    Fertil Steril; 2020 Jul; 114(1):97-109. PubMed ID: 32553470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regimen of ovarian stimulation affects oocyte and therefore embryo quality.
    Bosch E; Labarta E; Kolibianakis E; Rosen M; Meldrum D
    Fertil Steril; 2016 Mar; 105(3):560-570. PubMed ID: 26826273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.
    Lin G; Zhong X; Li S; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1215755. PubMed ID: 38027219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of GH Administration on Oocyte and Zygote Quality in Young Women With Repeated Implantation Failure After IVF.
    Tesarik J; Galán-Lázaro M; Conde-López C; Chiara-Rapisarda AM; Mendoza-Tesarik R
    Front Endocrinol (Lausanne); 2020; 11():519572. PubMed ID: 33117271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility.
    Matalliotakis IM; Cakmak H; Mahutte N; Fragouli Y; Arici A; Sakkas D
    Fertil Steril; 2007 Dec; 88(6):1568-72. PubMed ID: 17349642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.
    Zhang Y; Zhang C; Shu J; Guo J; Chang HM; Leung PCK; Sheng JZ; Huang H
    Hum Reprod Update; 2020 Feb; 26(2):247-263. PubMed ID: 32045470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.
    Skillern A; Leonard W; Pike J; Mak W
    J Assist Reprod Genet; 2021 May; 38(5):1055-1060. PubMed ID: 33534048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone co-treatment on controlled ovarian stimulation in normal ovarian response women can improve embryo quality.
    Liu X; Bai H; Xie J; Shi J
    Gynecol Endocrinol; 2019 Sep; 35(9):787-791. PubMed ID: 30907187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL; Wang L; Lv F; Huang XM; Wang LP; Pan Y; Zhang XM
    Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of
    Chen Y; Tao L; Lin Y; Li X; Ma C
    Gynecol Endocrinol; 2020 Nov; 36(11):955-958. PubMed ID: 32172647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.